Chemical formula: C₉H₁₁NO₄ Molecular mass: 197.188 g/mol PubChem compound: 6047
Levodopa is indicated for:
Population group: only adults (18 years old or older)
Levodopa is indicated for the intermittent treatment of OFF episodes in patients with Parkinson’s disease treated with carbidopa/levodopa.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Levodopa is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
